Comment
doi: 10.1159/000512021.
Epub 2020 Dec 1.
Surrogate Outcomes: An Inevitable Limitation of Hyperbilirubinemia-Driven Randomized Controlled Trials
Affiliations
- PMID: 33260178
- DOI: 10.1159/000512021
Item in Clipboard
Comment
Surrogate Outcomes: An Inevitable Limitation of Hyperbilirubinemia-Driven Randomized Controlled Trials
Neonatology.
2020.
No abstract available
Comment on
-
The Choice of Population and Outcomes in Neonatal Trials on Hyperbilirubinemia: Are They Relevant? An Analysis of Cochrane Neonatal Reviews.Neonatology. 2020;117(6):687-693. doi: 10.1159/000511656. Epub 2020 Dec 2. Neonatology. 2020. PMID: 33264799
Similar articles
-
Re: Randomized controlled trial of fluid supplementation in term neonates with severe hyperbilirubinemia.J Pediatr. 2006 Oct;149(4):581; author reply 581-2. doi: 10.1016/j.jpeds.2006.05.006. J Pediatr. 2006. PMID: 17011345 No abstract available.
-
The influence of massage on neonatal hyperbilirubinemia: a meta-analysis of randomized controlled trials.J Matern Fetal Neonatal Med. 2019 Sep;32(18):3109-3114. doi: 10.1080/14767058.2018.1455183. Epub 2018 Apr 9. J Matern Fetal Neonatal Med. 2019. PMID: 29631455
-
Enduring controversies in the management of hyperbilirubinemia in preterm neonates.Semin Fetal Neonatal Med. 2010 Jun;15(3):136-40. doi: 10.1016/j.siny.2009.12.003. Epub 2010 Jan 12. Semin Fetal Neonatal Med. 2010. PMID: 20060792 Review.
-
Phototherapy for neonatal hyperbilirubinemia: six-year follow-up of the National Institute of Child Health and Human Development clinical trial.Pediatrics. 1990 Apr;85(4):455-63. Pediatrics. 1990. PMID: 2179848 Clinical Trial.
-
The effect of triiodothyronine on neonatal hyperbilirubinemia.J Pediatr. 1966 Mar;68(3):413-7. doi: 10.1016/s0022-3476(66)80244-5. J Pediatr. 1966. PMID: 5323401 Clinical Trial. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
